Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules.

Azakir BA, Di Fulvio S, Salomon S, Brockhoff M, Therrien C, Sinnreich M.

J Biol Chem. 2017 Jul 28;292(30):12543. doi: 10.1074/jbc.A112.391722. No abstract available.

2.

Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.

Azakir BA, Di Fulvio S, Kinter J, Sinnreich M.

J Biol Chem. 2017 Jul 28;292(30):12542. doi: 10.1074/jbc.A111.329078. No abstract available.

3.

PGC-1α modulates necrosis, inflammatory response, and fibrotic tissue formation in injured skeletal muscle.

Dinulovic I, Furrer R, Di Fulvio S, Ferry A, Beer M, Handschin C.

Skelet Muscle. 2016 Nov 8;6:38. eCollection 2016.

4.

Proteasome inhibitors increase missense mutated dysferlin in patients with muscular dystrophy.

Azakir BA, Erne B, Di Fulvio S, Stirnimann G, Sinnreich M.

Sci Transl Med. 2014 Aug 20;6(250):250ra112. doi: 10.1126/scitranslmed.3009612. Epub 2014 Aug 20. Retraction in: Sci Transl Med. 2017 Jun 7;9(393):null.

5.

Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy.

Castets P, Lin S, Rion N, Di Fulvio S, Romanino K, Guridi M, Frank S, Tintignac LA, Sinnreich M, Rüegg MA.

Cell Metab. 2013 May 7;17(5):731-44. doi: 10.1016/j.cmet.2013.03.015. Epub 2013 Apr 18.

6.

Modular dispensability of dysferlin C2 domains reveals rational design for mini-dysferlin molecules.

Azakir BA, Di Fulvio S, Salomon S, Brockhoff M, Therrien C, Sinnreich M.

J Biol Chem. 2012 Aug 10;287(33):27629-36. doi: 10.1074/jbc.M112.391722. Epub 2012 Jun 26. Retraction in: J Biol Chem. 2017 Jul 28;292(30):12543.

7.

Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.

Azakir BA, Di Fulvio S, Kinter J, Sinnreich M.

J Biol Chem. 2012 Mar 23;287(13):10344-54. doi: 10.1074/jbc.M111.329078. Epub 2012 Feb 8. Retraction in: J Biol Chem. 2017 Jul 28;292(30):12542.

8.

Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation.

Di Fulvio S, Azakir BA, Therrien C, Sinnreich M.

PLoS One. 2011;6(12):e28563. doi: 10.1371/journal.pone.0028563. Epub 2011 Dec 8. Retraction in: PLoS One. 2018 Jan 29;13(1):e0192239.

9.

Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle.

Azakir BA, Di Fulvio S, Therrien C, Sinnreich M.

PLoS One. 2010 Apr 12;5(4):e10122. doi: 10.1371/journal.pone.0010122.

10.

Characterization of lipid binding specificities of dysferlin C2 domains reveals novel interactions with phosphoinositides.

Therrien C, Di Fulvio S, Pickles S, Sinnreich M.

Biochemistry. 2009 Mar 24;48(11):2377-84. doi: 10.1021/bi802242r.

PMID:
19253956
11.

Long-term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trial.

Belizán JM, Villar J, Bergel E, del Pino A, Di Fulvio S, Galliano SV, Kattan C.

BMJ. 1997 Aug 2;315(7103):281-5.

Supplemental Content

Loading ...
Support Center